Olanzapine
NDC 67184-0564, Olanzapine, tablet, from Qilu Pharmaceutical Co., Ltd..
- Product NDC
- 67184-0564
- Status
- Listed
- Labeler
- Qilu Pharmaceutical Co., Ltd.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204319
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0564 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OLANZAPINE10 mg/1
Pharmacologic classes
Atypical Antipsychotic [EPC]
| Package NDC | NDC-11 | Package |
|---|
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/6077f5c4-01d7-4c1d-97a0-cb859f98ce68
Use it
Look up 67184-0564 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0564 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67184-0564. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.